Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosloff

Showing results (201-210 of 221) with videos related to

Pageof 23
Sort By:
Open Forum Infectious Diseases|November 30, 2022
Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART)Jessica M Fogel, Kidist Zewdie, William A Clarke, et al.
Plos Medicine|September 8, 2023
Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS)Eveline Klinkenberg, Sian Floyd, Kwame Shanaube, et al.
Plos One|December 17, 2021
Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART)Wendy Grant-McAuley, Ethan Klock, Oliver Laeyendecker, et al.
BMC Infectious Diseases|May 21, 2017
Erratum to: Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessmentEshan U Patel, Jordyn Manucci, Erin M Kahle, et al.
BMC Infectious Diseases|October 2, 2015
Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessmentEshan U Patel, Jordyn Manucci, Erin M Kahle, et al.
Journal of the International AIDS Society|July 1, 2022
HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART)Jessica M Fogel, Ethan A Wilson, Estelle Piwowar-Manning, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
An engineered nanobody inhibitor for molecular-to-circuit control of opioid receptor functionZoé Valbret, Paul J Lamothe-Molina, Sofia Papadogkonaki, et al.
Journal of the International AIDS Society|February 20, 2020
Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART)Susan H Eshleman, Estelle Piwowar-Manning, Ethan A Wilson, et al.
Journal of Clinical Microbiology|July 17, 2020
A Comprehensive Genomics Solution for HIV Surveillance and Clinical Monitoring in Low-Income SettingsDavid Bonsall, Tanya Golubchik, Mariateresa de Cesare, et al.
BMC Infectious Diseases|November 11, 2022
Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatmentWendy Grant-McAuley, Oliver Laeyendecker, Daniel Monaco, et al.
Pageof 23

Showing results (201-210 of 221) with videos related to

Sort By:
Pageof 23
Open Forum Infectious Diseases|November 30, 2022
Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART)Jessica M Fogel, Kidist Zewdie, William A Clarke, et al.
Plos Medicine|September 8, 2023
Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS)Eveline Klinkenberg, Sian Floyd, Kwame Shanaube, et al.
Plos One|December 17, 2021
Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART)Wendy Grant-McAuley, Ethan Klock, Oliver Laeyendecker, et al.
BMC Infectious Diseases|May 21, 2017
Erratum to: Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessmentEshan U Patel, Jordyn Manucci, Erin M Kahle, et al.
BMC Infectious Diseases|October 2, 2015
Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessmentEshan U Patel, Jordyn Manucci, Erin M Kahle, et al.
Journal of the International AIDS Society|July 1, 2022
HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART)Jessica M Fogel, Ethan A Wilson, Estelle Piwowar-Manning, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
An engineered nanobody inhibitor for molecular-to-circuit control of opioid receptor functionZoé Valbret, Paul J Lamothe-Molina, Sofia Papadogkonaki, et al.
Journal of the International AIDS Society|February 20, 2020
Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART)Susan H Eshleman, Estelle Piwowar-Manning, Ethan A Wilson, et al.
Journal of Clinical Microbiology|July 17, 2020
A Comprehensive Genomics Solution for HIV Surveillance and Clinical Monitoring in Low-Income SettingsDavid Bonsall, Tanya Golubchik, Mariateresa de Cesare, et al.
BMC Infectious Diseases|November 11, 2022
Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatmentWendy Grant-McAuley, Oliver Laeyendecker, Daniel Monaco, et al.
Pageof 23